Evelijn Zeijdner

1.6k total citations · 1 hit paper
15 papers, 1.3k citations indexed

About

Evelijn Zeijdner is a scholar working on Pediatrics, Perinatology and Child Health, Pharmaceutical Science and Nutrition and Dietetics. According to data from OpenAlex, Evelijn Zeijdner has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pediatrics, Perinatology and Child Health, 4 papers in Pharmaceutical Science and 3 papers in Nutrition and Dietetics. Recurrent topics in Evelijn Zeijdner's work include Drug Solubulity and Delivery Systems (3 papers), Advanced Drug Delivery Systems (3 papers) and Protein purification and stability (2 papers). Evelijn Zeijdner is often cited by papers focused on Drug Solubulity and Delivery Systems (3 papers), Advanced Drug Delivery Systems (3 papers) and Protein purification and stability (2 papers). Evelijn Zeijdner collaborates with scholars based in Netherlands, United Kingdom and Belgium. Evelijn Zeijdner's co-authors include Mans Minekus, Joanna Wragg, Agnes G. Oomen, Willy Verstraete, Greet Schoeters, Tom Van de Wiele, Christa Cornelis, Adriënne J.A.M. Sips, J.H. van Wijnen and Alfons Hack and has published in prestigious journals such as Environmental Science & Technology, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Evelijn Zeijdner

15 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of Five In Vitro Digestion Models To Study the Bioaccessibility of Soil Contaminants

2002 668 citations Agnes G. Oomen, Alfons Hack et al. Environmental Science & Technology profile →

Peers

Countries citing papers authored by Evelijn Zeijdner

Since Specialization

Citations

This map shows the geographic impact of Evelijn Zeijdner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evelijn Zeijdner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evelijn Zeijdner more than expected).

Fields of papers citing papers by Evelijn Zeijdner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evelijn Zeijdner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evelijn Zeijdner. The network helps show where Evelijn Zeijdner may publish in the future.

Co-authorship network of co-authors of Evelijn Zeijdner

This figure shows the co-authorship network connecting the top 25 collaborators of Evelijn Zeijdner. A scholar is included among the top collaborators of Evelijn Zeijdner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evelijn Zeijdner. Evelijn Zeijdner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for ‘Trial within Cohorts’ study designs 2023 ·BMC Cancer ·(unknown), (unknown), Maureen J.B. Aarts, Axel Bex, Haiko J. Bloemendal, (unknown), Paul Hamberg, Karin H. Herbschleb, Tom van der Hulle, Brunolf W. Lagerveld, (unknown), Sjoukje F. Oosting, Johannes V. van Thienen, (unknown), Hans M. Westgeest, Evelijn Zeijdner, Katja K.H. Aben, Corina van den Hurk, Patricia Zondervan, Adriaan D. Bins	3
2	Evaluation of two dynamic in vitro models simulating fasted and fed state conditions in the upper gastrointestinal tract (TIM-1 and tiny-TIM) for investigating the bioaccessibility of pharmaceutical compounds from oral dosage forms 2015 ·International Journal of Pharmaceutics ·Miriam Verwei, Mans Minekus, Evelijn Zeijdner, Ronald Schilderink, R. Havenaar	90
3	A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices 2014 ·European Journal of Pharmaceutical Sciences ·Joost Westerhout, Evita van de Steeg, (unknown), Evelijn Zeijdner, Cyrille Krul, Miriam Verwei, Heleen M. Wortelboer	99
4	Dynamic gastro-intestinal in vitro model (TIM) for reliable prediction of stability, availability for absorption, and luminal efficacy of clinical foods and ingredients 2014 ·PharmaNutrition ·R. Havenaar, Susann Bellmann, Evelijn Zeijdner	4
5	Food-dependent disintegration of immediate release fosamprenavir tablets: In vitro evaluation using magnetic resonance imaging and a dynamic gastrointestinal system 2010 ·European Journal of Pharmaceutics and Biopharmaceutics ·Joachim Brouwers, (unknown), (unknown), Guus Duchateau, Pieter Annaert, Patrick Augustijns, Evelijn Zeijdner	77
6	Release of 5-aminosalicylate from an MMX mesalamine tablet during transit through a simulated gastrointestinal tract system 2007 ·Advances in Therapy ·Srini Tenjarla, (unknown), Evelijn Zeijdner, Roberto Edoardo Villa, Luigi Moro	49
7	Use of a gastro-intestinal model and gastroplus[tm] for the prediction of in vivo performance 2006 ·TNO Repository ·(unknown), Patricia Connolly, (unknown), (unknown), Mans Minekus, R. Havenaar, Evelijn Zeijdner	26
8	The use of a dynamic in vitro model of the gastrointestinal tract (TIM) in studying mycotoxin adsorbents 2004 ·TNO Repository ·Evelijn Zeijdner, Giuseppina Avantaggiato, (unknown), (unknown), A. Visconti, R. Havenaar	3
9	A Dynamic Artificial Gastrointestinal System for Studying the Behavior of Orally Administered Drug Dosage Forms Under Various Physiological Conditions 2004 ·Pharmaceutical Research ·S. Blanquet, Evelijn Zeijdner, Erick Beyssac, (unknown), Sylvain Denis, R. Havenaar, Monique Alric	221
10	Efficacy of a natural magnesium smectite against aflatoxin B1 and zearalenone tested in a dynamic in vitro model of the gastric and small intestine simulating the pig 2003 ·TNO Repository ·Evelijn Zeijdner, (unknown), (unknown), R. Havenaar, (unknown)	1
11	Comparison of Five In Vitro Digestion Models To Study the Bioaccessibility of Soil Contaminants breakdown → 2002 ·Environmental Science & Technology ·Agnes G. Oomen, Alfons Hack, Mans Minekus, Evelijn Zeijdner, Christa Cornelis, Greet Schoeters, Willy Verstraete, Tom Van de Wiele, Joanna Wragg, C.J.M. Rompelberg, Adriënne J.A.M. Sips, J.H. van Wijnen	668
12	The fate of orally-administered drug compounds during passage through the gastrointestinal tract - a case study using a dynamic in vitro model 2000 ·TNO Repository ·Evelijn Zeijdner, R. Havenaar	1
13	Dynamic System of the Gastrointestinal Tract to Study Nutritional Quality 2000 ·IFAC Proceedings Volumes ·R. Havenaar, Mans Minekus, Evelijn Zeijdner, Monique A. M. Smeets, (unknown), Koen Venema	1
14	Essential fatty acid status in plasma phospholipids of mother and neonate after multiple pregnancy 1997 ·Prostaglandins Leukotrienes and Essential Fatty Acids ·Evelijn Zeijdner, A.C. van Houwelingen, Arnold D.M. Kester, Gerard Hornstra	29
15	Essential fatty acid status measured in umbilical vessel walls of infants born after a multiple pregnancy 1996 ·Early Human Development ·(unknown), Evelijn Zeijdner, Adriana C van Houwelingen, Arnold D.M. Kester, Monique D.M. Al, Tom H.M. Hasaart, Gerard Hornstra	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact